The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $34.42

Today's change+0.49 +1.44%
Updated December 5 4:02 PM EST. Delayed by at least 15 minutes.
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $34.42

Today's change+0.49 +1.44%
Updated December 5 4:02 PM EST. Delayed by at least 15 minutes.

Novo Nordisk A/S up (U.S.)$0.49

Novo Nordisk A/S closed up Monday by (U.S.)$0.49 or 1.44% to (U.S.)$34.42. Over the last five days, shares have gained 5.78%, but are down 40.74% for the last year to date. Shares have underperformed the S&P 500 by 45.05% during the last year.

Key company metrics

  • Open(U.S.) $34.34
  • Previous close(U.S.) $33.93
  • High(U.S.) $34.47
  • Low(U.S.) $34.18
  • Bid / Ask-- / --
  • YTD % change-40.74%
  • Volume5,548,691
  • Average volume (10-day)4,664,072
  • Average volume (1-month)5,240,728
  • Average volume (3-month)4,029,950
  • 52-week range(U.S.) $30.89 to (U.S.) $59.00
  • Beta0.80
  • Trailing P/E16.29×
  • P/E 1 year forward15.34×
  • Forward PEG1.74×
  • Indicated annual dividend(U.S.) $0.91
  • Dividend yield2.63%
  • Trailing EPS(U.S.) $2.11
Updated December 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+33.74%

Based on its net profit margin of 33.74%, Novo Nordisk A/S is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.28%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue27,53727,45927,21228,876
Total other revenue--------
Total revenue27,53727,45927,21228,876
Gross profit23,55123,41422,97824,268
Total cost of revenue3,9864,0454,2344,608
Total operating expense15,11714,96214,90317,751
Selling / general / administrative7,8757,7407,6499,203
Research & development3,4583,3313,3044,034
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total-202-154-284-94
Operating income12,42012,49712,30911,125
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax12,30112,60211,95310,314
Income after tax9,8039,9689,4558,258
Income tax, total2,4982,6342,4982,056
Net income9,8039,9689,4558,258
Total adjustments to net income--------
Net income before extra. items9,8039,9689,4558,258
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9,8039,9689,4558,258
Inc. avail. to common incl. extra. items9,8039,9689,4558,258
Diluted net income9,8039,9689,4558,258
Dilution adjustment--00--
Diluted weighted average shares2,5312,5412,5502,551
Diluted EPS excluding extraordinary itemsvalue per share3.873.923.713.24
Dividends per sharevalue per share0.000.000.006.40
Diluted normalized EPSvalue per share3.873.923.713.24